LABD:ARCA-Direxion Daily S&P Biotech Bear 3X Shares (USD)

ETF | Trading--Inverse Equity | NYSE Arca

Last Closing

USD 7.83

Change

+0.16 (+2.09)%

Market Cap

USD 0.10B

Volume

0.01B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index. The index includes domestic companies from the biotechnology industry. The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.55%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SH ProShares Short S&P500 0.89 %

+0.01 (+0.09%)

USD 0.99B
SOXS Direxion Daily Semiconductor B.. 0.97 %

+0.31 (+1.45%)

USD 0.76B
SPXU ProShares UltraPro Short S&P50.. 0.91 %

-0.02 (-0.07%)

USD 0.58B
PSQ ProShares Short QQQ 0.95 %

-0.17 (-0.41%)

USD 0.56B
SDS ProShares UltraShort S&P500 0.89 %

N/A

USD 0.54B
SPXS Direxion Daily S&P 500® Bear .. 0.95 %

N/A

USD 0.48B
TZA Direxion Daily Small Cap Bear .. 0.95 %

+0.91 (+4.82%)

USD 0.32B
SDOW ProShares UltraPro Short Dow30 0.95 %

+0.11 (+0.63%)

USD 0.31B
QID ProShares UltraShort QQQ 0.95 %

-0.38 (-0.96%)

USD 0.25B
YANG Direxion Daily FTSE China Bear.. 1.02 %

+0.23 (+2.73%)

USD 0.21B

ETFs Containing LABD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.20% 38% F 8% B-
Dividend Return 0.69% 21% F 33% F
Total Return -18.51% 36% F 7% C-
Trailing 12 Months  
Capital Gain -37.91% 41% F 5% F
Dividend Return 3.51% 51% F 51% F
Total Return -34.40% 38% F 6% D-
Trailing 5 Years  
Capital Gain -98.32% 11% F 1% F
Dividend Return 0.83% 11% F 2% F
Total Return -97.49% 11% F 1% F
Average Annual (5 Year Horizon)  
Capital Gain 30.44% 73% C 90% A-
Dividend Return 31.07% 73% C 89% A-
Total Return 0.63% 23% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 974.44% 27% F 1% F
Risk Adjusted Return 3.19% 66% D+ 28% F
Market Capitalization 0.10B 66% D+ 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.